Venmax Drugs and Pharmaceuticals Limited Stock

Equities

531015

INE154G01022

Chart Venmax Drugs and Pharmaceuticals Limited

Duration

Period

Style

Dynamic Chart

Latest news about Venmax Drugs and Pharmaceuticals Limited

Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-14	CI
Venmax Drugs and Pharmaceuticals Limited Approves Resignation of Sadan Grover from the Post of Company Secretary & Compliance Officer	04-20	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-30	CI
Venmax Drugs and Pharmaceuticals Limited Announces Change in Management	01-16	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-15	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-30	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-04	CI
Venmax Drugs and Pharmaceuticals Limited Auditor Raises 'Going Concern' Doubt	22-09-15	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-07-30	CI
Venmax Drugs and Pharmaceuticals Limited Approves Shifting of Registered Office	22-07-30	CI
Venmax Drugs and Pharmaceuticals Limited Proposes the Resignation of Shri Ramakrishnaiah Appanaboyana as Independent Director	22-07-23	CI
Venmax Drugs and Pharmaceuticals Limited Announces Executive Changes	21-02-13	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-13	CI
Venmax Drugs and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-11	CI

More news

Managers and Directors - Venmax Drugs and Pharmaceuticals Limited

Managers	Title	Age	Since
Nooka Krishnaiah CEO	Chief Executive Officer	35	15-09-02
Pradeep Kumar DFI	Director of Finance/CFO	-	-

Members of the board	Title	Age	Since
Ramakrishnaiah Appanaboyina BRD	Director/Board Member	-	05-12-30
Nooka Krishnaiah CEO	Chief Executive Officer	35	15-09-02

More insiders

Company Profile

Sector

Calendar

2024-08-11 - Q1 2025 Earnings Release (Projected)

More about the company